Quick Answer
Quantum Biopharma Ltd. reported Total Assets of $11.16 million for fiscal year 2025.
Quantum Biopharma Ltd. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $11.16M -34.8% |
$17.12M -2.0% |
$17.47M -54.5% |
$38.41M -39.0% |
$62.96M +50.0% |
$41.97M |
| R&D Expense | $2.76M -54.6% |
$6.08M +57.6% |
$3.86M -44.2% |
$6.91M +9.2% |
$6.33M -19.2% |
$7.83M |
- Quantum Biopharma Ltd. reported Total Assets of $11.16 million for fiscal year 2025.
- Quantum Biopharma Ltd. showed a decrease of -34.8% in Total Assets compared to the prior fiscal year.
- Quantum Biopharma Ltd. reported R&D Expense of $2.76 million for fiscal year 2025.
- Quantum Biopharma Ltd. showed a decrease of -54.6% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: